Disclosures for "Intracerebroventricular Injection of Autologous Adipose-Derived Stem Cells for the Treatment of Alzheimer’s Disease: Experience with Two Cohorts in a “First-in-Human” Phase 1 FDA Trial."
-
Dr. Duma has received personal compensation for serving as an employee of Regeneration Biomedical, Inc.. Dr. Duma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longeviti Inc.. Dr. Duma has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Regeneration Biomedical, Inc.. Dr. Duma has stock in Regeneration Biomedical, Inc.. Dr. Duma has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Keirstead has received personal compensation for serving as an employee of AIVITA Biomedical. Dr. Keirstead has received personal compensation for serving as an employee of Human Immunome Project. Dr. Keirstead has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Immunis . Dr. Keirstead has stock in AIVITA Biomedical. Dr. Keirstead has stock in Immunis. Dr. Keirstead has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Nistor has received personal compensation for serving as an employee of Aivita Biomedical. Dr. Nistor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life and Land Prospect.
-
Mr. Farmer has nothing to disclose.
-
Mr. Lynn has received personal compensation for serving as an employee of Regeneration Biomedical, Inc..
-
Miss Harris has nothing to disclose.
-
Miss Buxton has nothing to disclose.
-
Prof. Chung has nothing to disclose.
-
Ms. Hareng has nothing to disclose.
-
Dr. Cho has nothing to disclose.